170 related articles for article (PubMed ID: 30312283)
1. Determinants of Corneal Endothelial Cell Loss After Trabeculectomy With Mitomycin C.
Higashide T; Nishino T; Sakaguchi K; Yamada Y; Sugiyama K
J Glaucoma; 2019 Jan; 28(1):61-67. PubMed ID: 30312283
[TBL] [Abstract][Full Text] [Related]
2. Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results.
Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
J Glaucoma; 2020 Mar; 29(3):155-160. PubMed ID: 32108690
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study.
Iwao K; Inatani M; Seto T; Takihara Y; Ogata-Iwao M; Okinami S; Tanihara H
J Glaucoma; 2014 Feb; 23(2):88-94. PubMed ID: 22895522
[TBL] [Abstract][Full Text] [Related]
4. Trabeculectomy With Mitomycin C or Ahmed Valve Implantation in Eyes With Uveitic Glaucoma.
Bettis DI; Morshedi RG; Chaya C; Goldsmith J; Crandall A; Zabriskie N
J Glaucoma; 2015; 24(8):591-9. PubMed ID: 25393037
[TBL] [Abstract][Full Text] [Related]
5. Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Lim SH; Cha SC
J Glaucoma; 2017 Apr; 26(4):303-310. PubMed ID: 26709498
[TBL] [Abstract][Full Text] [Related]
6. Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.
Supawavej C; Nouri-Mahdavi K; Law SK; Caprioli J
J Glaucoma; 2013 Jan; 22(1):52-9. PubMed ID: 21623217
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
8. Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Kashiwagi K; Kogure S; Mabuchi F; Chiba T; Yamamoto T; Kuwayama Y; Araie M;
Acta Ophthalmol; 2016 Nov; 94(7):e561-e570. PubMed ID: 27156361
[TBL] [Abstract][Full Text] [Related]
9. Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
Komae K; Takamoto M; Tanaka R; Aihara M; Ohtomo K; Okinaga K; Matsuda J; Nakahara H; Fujino Y; Kaburaki T
J Glaucoma; 2017 Jul; 26(7):603-607. PubMed ID: 28369000
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease.
Almobarak FA; Alharbi AH; Morales J; Aljadaan I
J Glaucoma; 2016 Jun; 25(6):528-32. PubMed ID: 26900830
[TBL] [Abstract][Full Text] [Related]
11. Transconjunctival Revision With Mitomycin-C Following Failed Trabeculectomy.
Panarelli JF; Vinod K; Huang G; Sidoti PA
J Glaucoma; 2016 Jul; 25(7):618-22. PubMed ID: 26950580
[TBL] [Abstract][Full Text] [Related]
12. Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma.
Sheha H; Kheirkhah A; Taha H
J Glaucoma; 2008; 17(4):303-7. PubMed ID: 18552616
[TBL] [Abstract][Full Text] [Related]
13. Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
Leinonen S; Kotaniemi K; Kivelä T; Majander A
JAMA Ophthalmol; 2015 Nov; 133(11):1323-8. PubMed ID: 26402863
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of early IOP in mitomycin-C augmented trabeculectomy.
Alwitry A; Moodie J; Rotchford A; Abedin A; Patel V; King AJ
J Glaucoma; 2007; 16(7):616-21. PubMed ID: 18091180
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Trabeculectomy Surgery Outcomes With Mitomycin-C Applied by Intra-Tenon Injection Versus Sponge.
Lim MC; Hom B; Watnik MR; Brandt JD; Altman AR; Paul T; Tong MG
Am J Ophthalmol; 2020 Aug; 216():243-256. PubMed ID: 32173343
[TBL] [Abstract][Full Text] [Related]
16. Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma.
Nash DL; Crouch ER; Crouch ER
J Glaucoma; 2017 Feb; 26(2):e58-e63. PubMed ID: 28146442
[TBL] [Abstract][Full Text] [Related]
17. Intermediate and Long-term Outcomes of Mitomycin C-enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma.
Almobarak FA; Alharbi AH; Morales J; Aljadaan I
J Glaucoma; 2017 May; 26(5):478-485. PubMed ID: 28234684
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for developing avascular filtering bleb after fornix-based trabeculectomy with mitomycin C.
Hirooka K; Mizote M; Baba T; Takagishi M; Shiraga F
J Glaucoma; 2009; 18(4):301-4. PubMed ID: 19365195
[TBL] [Abstract][Full Text] [Related]
20. The increasingly iatrogenic indications for mitomycin C trabeculectomy over 10 years.
Macdonald E; Mukherjee S; Jay J
Can J Ophthalmol; 2009 Apr; 44(2):205-8. PubMed ID: 19491957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
